TY  - JOUR
AU  - Vannappagari, Vani
AU  - Thorne, Claire
AU  - for APR and EPPICC
PY  - 2019
DO  - 10.1097/QAI.0000000000002035
UR  - https://hdl.handle.net/10668/26288
T2  - Journal of acquired immune deficiency syndromes (1999)
AB  - Birth outcome data with dolutegravir exposure during pregnancy, particularly in the first trimester, are needed. Data were prospectively collected from the Antiretroviral Pregnancy Registry and European Pregnancy and Paediatric HIV Cohort...
LA  - en
KW  - Abnormalities, Drug-Induced
KW  - Abortion, Induced
KW  - Abortion, Spontaneous
KW  - Adolescent
KW  - Adult
KW  - Anti-HIV Agents
KW  - CD4 Lymphocyte Count
KW  - Cohort Studies
KW  - Female
KW  - Fertilization
KW  - Heterocyclic Compounds, 3-Ring
KW  - Humans
KW  - Infant, Low Birth Weight
KW  - Infant, Newborn
KW  - Oxazines
KW  - Piperazines
KW  - Pregnancy
KW  - Pregnancy Complications, Infectious
KW  - Pregnancy Outcome
KW  - Pregnancy Trimester, First
KW  - Pregnancy Trimester, Second
KW  - Premature Birth
KW  - Prenatal Exposure Delayed Effects
KW  - Pyridones
KW  - Registries
KW  - Stillbirth
KW  - United States
KW  - Young Adult
TI  - Pregnancy and Neonatal Outcomes Following Prenatal Exposure to Dolutegravir.
TY  - research article
VL  - 81
ER  -